Anti Dumping Policy and its Effect on Indian Pharmaceutical Sector
Astha Srivastava1, Shivangi Sinha2
1Astha Srivastava, Assistant Professor, Bharati Vidyapeeth Deemed to be University, New Law College, Pune (Maharashtra), India.
2Shivangi Sinha, Assistant Professor, Bharati Vidyapeeth Deemed to be University, New Law College, Pune (Maharashtra), India.
Manuscript received on 18 August 2019 | Revised Manuscript received on 29 August 2019 | Manuscript Published on 06 September 2019 | PP: 1082-1083 | Volume-8 Issue- 6S, August 2019 | Retrieval Number: F12070886S19/19©BEIESP | DOI: 10.35940/ijeat.F1207.0886S19
Open Access | Editorial and Publishing Policies | Cite | Mendeley | Indexing and Abstracting
© The Authors. Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Abstract: Trade policy regimes are changing and growing towards a protectionist attitude. Liberal trade policies might harm the trade and commerce of a country. Therefore GATT contains some measures for the member countries to impose higher protection against imports. One of these measures is known as Antidumping. When a country sends its products to another country and sells it at less than the normal value it is known as dumping. Dumping results into harm to the established market practices and anti-competitive activities. Significance Statement: The paper aims at studying anti-dumping policies prevalent in our country and how dumping is effecting the pharmaceutical sector of the country.
Keywords: Antidumping, GATT, Competition Act, Drug Pricing Control order, Predatory Pricing.
Scope of the Article: Social Sciences